Related Experiment Videos

[Blood serum hepatocyte growth factor in children with chronic renal failure treated with CAPD and HD]

K Szprynger1, M Szczepańska, A Morawiec-Knysak

  • 1Katedry i Kliniki Nefrologii, Endokrynologii i Chorób Metabolicznych Wieku Dzieciecego w Zabrzu.

Insights

Hepatocyte growth factor (HGF) levels were highest in children on hemodialysis (HD) compared to peritoneal dialysis (CAPD) and healthy controls. No significant differences were found between HD patients and healthy children.

Area of Science:

  • Nephrology
  • Biochemistry
  • Pediatrics

Context:

  • Chronic renal failure (CRF) impacts growth and development in children.
  • Dialysis treatments, including continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD), are common for pediatric CRF.
  • Hepatocyte growth factor (HGF) plays a role in tissue repair and regeneration, including renal tissues.

Purpose:

  • To analyze and compare serum hepatocyte growth factor (HGF) concentrations in children with chronic renal failure undergoing CAPD and HD treatments.
  • To investigate potential correlations between HGF levels and clinical parameters in pediatric dialysis patients.

Summary:

  • Serum HGF concentrations were measured in 20 children on CAPD, 20 on HD, and 10 healthy controls.
  • Children on HD exhibited the highest HGF levels, comparable to healthy children, while CAPD patients showed lower concentrations.
  • No significant correlations were found between HGF levels and dialysis duration, blood pressure, lipid profile, calcium, or hemoglobin levels.

Impact:

  • Findings suggest that HD may be associated with higher HGF levels in pediatric patients with CRF.
  • Lower HGF in CAPD patients might be due to factors like heparin absence or transperitoneal clearance.
  • Further research with larger cohorts is needed to explore HGF clearance in CAPD patients.

Related Concept Videos